POLARGO: Randomized phase III study of polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in relapsed/refractory diffuse large B-cell lymphoma Meeting Abstract
| Authors: | Matasar, M. J.; Haioun, C.; Sancho, J. M.; Viardot, A.; Hirata, J.; Perretti, T.; Musick, L.; McMillan, A. K. |
| Abstract Title: | POLARGO: Randomized phase III study of polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin in relapsed/refractory diffuse large B-cell lymphoma |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413906134 |
| DOI: | 10.1182/blood-2021-145857 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3568 -- Hybrid meeting, also took place online -- Source: Wos |
